-
Antibody Drug Conjugates Market Size to Surpass USD 36.22 Billion by 2034
20 Nov 2025 11:19 GMT
… in ensuring stable linker-drug combinations also hinder progress … ability to release cytotoxic drugs precisely at the … cells, reducing premature drug release. This technology … Astellas Pharma, Inc.
ADC Therapeutics SA
Recent Developments in the Antibody Drug …
-
Bayer gets EU approval for menopause drug Lynkuet
20 Nov 2025 00:58 GMT
… the first direct competition to Astellas' NK 3 antagonist Veozah … , with Astellas saying last month that sales of the drug in the …
-
Otsuka's HAE med Dawnzera, Lilly's oral SERD Inluriyo among drugs scoring EU endorsements
15 Nov 2025 00:57 GMT
… 3 study that showed the drug was associated with an 81% … (PRIME) pathway to speed up drugs that meet an unmet need … organization to have spearheaded a drug’s path from research all … generic version of Astellas and Pfizer’s prostate cancer drug Xtandi.
Viatris …
-
This Undervalued Biotech Might Have Just Proven Its Star Drug's Staying Power
12 Nov 2025 20:07 GMT
On Wednesday, Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) announced data from a post hoc analysis of the GALE extension study following five years of continuous treatment with Syfovre (pegcetacoplan injection) for geographic atrophy (GA) secondary to age- …
-
<![CDATA[A Review of Antibody-Drug Conjugates for the Treatment of Urothelial Carcinoma: The Rise of Enfortumab Vedotin]]>
06 Nov 2025 03:00 GMT
… toxicity management.
Introduction
Antibody-drug conjugates (ADCs) represent a … -ejfv (EV; Padcev; Astellas Pharma US and Seagen) … gov/drugs/resources-information-approved-drugs/ … associated with antibody drug conjugates and immunotherapy in …
-
<![CDATA[Rates of Drug Interactions Differentiate ARPIs for Treating mHSPC]]>
05 Nov 2025 02:18 GMT
… the drug-drug interaction issues with ARPIs?
They have drug-drug interaction … commonly used drugs—and they tested for the drug-drug interactions between … Roche, AstraZeneca, Merck, Medscape, UroToday, Astellas Pharma, Genzyme, Foundation Medicine, Bristol …
-
Transforming Drug Discovery and Development: Platform Technologies Expand Outsourcing Options
03 Nov 2025 23:17 GMT
… sophisticated monoclonal antibodies (mAbs), antibody–drug conjugates (ADCs), fusion proteins, … models.
CRDMOs Realign with Drug-Discovery Trends
Traditionally, contract …
7 Ubiquigent Enters Agreement with Astellas Subsidiary, Nanna Therapeutics [press …
-
"Significant shift" as NICE widens prostate cancer drug use
01 Nov 2025 21:19 GMT
… on NHS use of the drug marks a "significant shift … s 2021 decision on the drug as a first-line … of abiraterone rather than using Astellas' Xtandi (enzalutamide) and … (apalutamide), currently the two other drugs recommended in this setting.
The …
-
Ajinomoto, Astellas Enter ADC Technology Agreement
01 Nov 2025 20:09 GMT
… Astellas Pharma Inc. for the use of AJICAP—an antibody-drug … and stable conjugation of drugs to proteins such as … Ajinomoto Co. will support Astellas in its research and manufacturing … provision of uniform quality for Astellas Pharma’s development candidates, …
-
Zydus and Lupin shares in focus today after Astellas raises Mirabegron guidance by 80%
31 Oct 2025 08:35 GMT
… , a drug used to treat overactive bladder.
Global pharma major Astellas Pharma … its revenue guidance for the drug by nearly 80%, signaling strong … .
During its recent earnings call, Astellas also indicated that it won …
About
© 1995-2025